The role of glucagon-like peptide-1 (GlP-1) receptor agonists in patients with chronic kidney disease (CKD) and end-stage kidney disease (ESKD).Published in:CANNT Journal, 2025, v. 35, n. 1, p. 10By:Bleik, Adam;Kak, Karishma;Raco, Vanessa;Battistella, MarisaPublication type:Article
A review: Chronic kidney disease-associated pruritus (CKD-aP).Published in:CANNT Journal, 2025, v. 35, n. 1, p. 20By:huynh, AlinePublication type:Article
CANNT Board in Action.Published in:CANNT Journal, 2025, v. 35, n. 1, p. 8By:Howes, MeganPublication type:Article
letter from the Editors.Published in:CANNT Journal, 2025, v. 35, n. 1, p. 4By:Bachynski, Jovina;Marticorena, Rosa M.Publication type:Article
President's Message.Published in:CANNT Journal, 2025, v. 35, n. 1, p. 6By:Moonesar, AliciaPublication type:Article